Unisciti ai Dott. Rahul e Rohit Gosain mentre discutono preziose intuizioni sulla cura del cancro in brevi episodi, collegando i fornitori della comunità con i più recenti sviluppi in oncologia.
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
24 mins • May 21, 2025
Charts
- 112Increased by 20
- 166Decreased by 67
- 161Decreased by 31
- 54Decreased by 2
- 198Decreased by 84
Episodi recenti

May 21, 2025
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
24 mins

May 19, 2025
How to treat Small Cell Lung Cancer in 2025
23 mins

May 15, 2025
Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations
22 mins

May 12, 2025
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
21 mins

May 8, 2025
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
15 mins

Lingua
Inglese
Paese
Stati Uniti
Feed Host
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.